Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Entelos has signed an agreement with Pfizer that will enable the pharmaceuticals giant to continue research using the Entelos Cardiovascular PhysioLab platform. Financial terms were not disclosed.
Subscribe to our email newsletter
The Entelos Cardiovascular PhysioLab platform was originally built in collaboration with Pfizer.
“The pharmaceutical and medical communities recognize the importance of treating complex conditions much earlier in the disease process,” stated James Karis, president and CEO of Entelos. “We expect to use our new cardiovascular platform to conduct research that goes much deeper into the biology of heart disease to help identify novel approaches and treatments.”